|
2021
|
Invention
|
Live-attenuated virus vaccine.
This invention relates to a codon deoptimized severe acute respir... |
|
|
Invention
|
Live-attenuated virus vaccine. This invention relates to a codon deoptimized severe acute respira... |
|
2016
|
Invention
|
A scalable, low variation and efficient method for purification of tetanus toxoid and uses thereo... |
|
|
Invention
|
A scalable, low variation and efficient method for purification of diphtheria toxoid and uses the... |
|
2012
|
Invention
|
Recombinant ant-bovine iga antibody and uses thereof. A recombinant monoclonal anti-bovine IgA an... |
|
|
Invention
|
Recombinant anti-canine parvovirus antibody and uses thereof. A monovalent anti-canine parvovirus... |
|
2011
|
Invention
|
Monovalent human anti-hepatitis a virus antibody and uses thereof. The present invention relates ... |
|
|
Invention
|
Recombinant human bivalent diabody against rabies virus and uses thereof. The present invention p... |
|
2008
|
Invention
|
Chimeric tymovirus-like particles and process thereof. The present disclosure relates to chimeric... |
|
2006
|
Invention
|
Chimeric tymovirus-like particles. The present disclosure relates to chimeric tymovirus-like part... |
|
2005
|
Invention
|
Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16. The... |
|
2003
|
Invention
|
Noval vaccine formulation consisting of dna vaccine and inactivated virus. Disclosed herein is a ... |
|
2001
|
Invention
|
A noval vaccine formulation consisting of dna vaccine inactivated virus. Disclosed herein is a no... |
|
|
Invention
|
A novel vaccine formulation consisting of dna vaccine inactivated virus. Disclosed herein is a no... |
